Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Medicines ...

According to the report, owners don’t seek treatment until the itch symptoms are present for six weeks. Most veterinarians ...

The positive opinion for Zenrelia, or ilunocitinib, opens the way for the product's marketing authorization in the European Union in the next 60 days. The company said it expects to launch Zenrelia ...

The Canine Atopic Dermatitis Treatment Market size is expected to experience a considerable valuation bump, from USD 1,182.60 million in 2024 to USD 1,620.50 million in 2034. The updated report points ...

The diet is formulated to help manage atopic dermatitis in dogs and ... A significant number of these dogs often require a multimodal treatment plan, including targeted nutrition.